• Explore /
  • Poster
  • / DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.

DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.

Abstract Poster

Authors

null

LJ Amaral

Cedars-Sinai, Los Angeles, CA

LJ Amaral , Gillian Gresham , Nicholas A. Butowski , Katherine B. Peters , Akanksha Sharma , Ekokobe Fonkem , Jen-Tsan Chi , Santosh Kesari , Pao-hwa Lin , Stephen Lawrence Shiao , Mourad Tighiouart , Sungyong You , Jeremy David Rudnick , Stephen J. Freedland , Jethro Lisien Hu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Non-Glioma

Clinical Trial Registration Number

05708352

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS2103)

DOI

10.1200/JCO.2024.42.16_suppl.TPS2103

Abstract #

TPS2103

Poster Bd #

395a

Abstract Disclosures

Similar Posters

First Author: Jian Li Campian

First Author: Shu Tian

Poster

2023 ASCO Quality Care Symposium

Comprehensive institution-wide adoption of an ePRO treatment symptom reporting solution.

Comprehensive institution-wide adoption of an ePRO treatment symptom reporting solution.

First Author: Ian Kudel

First Author: Santosh Kesari